Skip to content

Acute Effects of Spirulina on Postprandial Glycemic Responses and Arterial Blood Pressure

Acute Effects of Three Doses of Spirulina in Glucose Beverages on Postprandial Glycemic Responses, Arterial Blood Pressure, and Subjective Appetite Responses: A Randomized Clinical Trial

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05484336
Enrollment
13
Registered
2022-08-02
Start date
2022-06-07
Completion date
2022-07-26
Last updated
2022-08-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Potential Abnormality of Glucose Tolerance, Appetitive Behavior, Blood Pressure

Keywords

blood glucose responses, blood pressure, spirulina, subjective appetite, blood glucose concentrations

Brief summary

This study investigated the effects of three doses of spirulina in glucose beverages on postprandial glycemic responses, arterial blood pressure, and subjective satiety.

Detailed description

This study aimed to determine the effects of three different doses (4, 6 and 8 g) of spirulina in glucose beverages on postprandial glycemic responses, blood pressure, and subjective appetite responses in healthy young adults.

Interventions

Thirteen healthy, with BMI between 18 and 29.9 kg/m2 (male: 3, female:10) after 10-14h fast, consumed 50g glucose diluted in 250ml, tested two times, in different visits, within 5-10min. Fingertip capillary blood glucose samples were taken at baseline, 15, 30, 45, 60, 90 and 120min.

OTHERBeverage containing 4g spirulina

Thirteen healthy, with BMI between 18 and 29.9 kg/m2 (male: 3, female:10) after 10-14h fast, consumed 50g glucose and 4g spirulina diluted in 250ml, tested once, within 5-10min. Fingertip capillary blood glucose samples were taken at baseline, 15, 30, 45, 60, 90 and 120min.

OTHERBeverage containing 6g spirulina

Thirteen healthy, with BMI between 18 and 29.9 kg/m2 (male: 3, female:10) after 10-14h fast, consumed 50g glucose and 6g spirulina diluted in 250ml, tested once, within 5-10min. Fingertip capillary blood glucose samples were taken at baseline, 15, 30, 45, 60, 90 and 120min.

OTHERBeverage containing 8g spirulina

Thirteen healthy, with BMI between 18 and 29.9 kg/m2 (male: 3, female:10) after 10-14h fast, consumed 50g glucose and 8g spirulina diluted in 250ml, tested once, within 5-10min. Fingertip capillary blood glucose samples were taken at baseline, 15, 30, 45, 60, 90 and 120min.

Sponsors

Agricultural University of Athens
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
OTHER
Masking
DOUBLE (Subject, Investigator)

Masking description

Double blind

Intervention model description

Crossover Assignment

Eligibility

Sex/Gender
ALL
Age
18 Years to 55 Years
Healthy volunteers
Yes

Inclusion criteria

* healthy * non-smokers * men and women * body mass index between 18 and 24.9 kg/m2 * normal blood pressure (systolic blood pressure \<120 mmHg and diastolic blood pressure \<80 mmHg) * normal fasting blood glucose concentrations (\<100 mg/dL)

Exclusion criteria

* Medical conditions (e.g., cardiovascular diseases, diabetes mellitus, kidney or liver conditions, severe clinical depression, gastrointestinal disorders) * Under medications known to affect glycemia (glucocorticoids, metformin, thiazide diuretics) * Allergy to spirulina * Pregnancy * Lactation * Competitive sports * Alcohol abuse * Drug dependency

Design outcomes

Primary

MeasureTime frameDescription
Capillary blood glucose responses2 hoursClinically useful change in blood glucose, defined as the restoration of glucose within normal limits during 2hr glucose tolerance test
Blood pressure2 hoursUseful change in systolic and diastolic blood pressure before and 2hr after consumption of the three doses of spirulina in beverages

Secondary

MeasureTime frameDescription
Subjective appetite ratings2 hoursUseful change in subjective appetite using visual analogue scales with a score 0 to 10 (given in form of booklet, one scale per page) at baseline, 15, 30, 45, 60, 90 and 120. The minimum or maximum score will be evaluated if it is better or worse depending on the appetite variable e.g. hunger, satiety, desire to eat etc.

Countries

Greece

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026